CLINICAL_TRIALS
trial_result
· 2022-05-13
Clinical Trial Update: Study of XL647 in Subjects With Non-Small-Cell Lung Cancer [Phase 2]
Summary
Phase 2 clinical trial update for XL647 in non-small-cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kadmon Corporation, LLC | Conditions: Non-small-cell Lung Cancer | Phase 2 | Status: COMPLETED